AF + HTN had more frequent ACE inhibitor (p < 0.001), Ca2+ channel inhibitor (p < 0.001), ARB (p < 0.001), statin (p = 0.017) and SSR inhibitor (p = 0.018) use (Supplementary Table 1). The gene discussed is ACE; the disease is atrial fibrillation.